Yamasaki, K.; Mukai, S.; Nagai, T.; Nakahara, K.; Fujii, M.; Terada, N.; Ohno, A.; Sato, Y.; Toda, Y.; Kataoka, H.;
et al. Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. Int. J. Mol. Sci. 2018, 19, 3708.
https://doi.org/10.3390/ijms19123708
AMA Style
Yamasaki K, Mukai S, Nagai T, Nakahara K, Fujii M, Terada N, Ohno A, Sato Y, Toda Y, Kataoka H,
et al. Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. International Journal of Molecular Sciences. 2018; 19(12):3708.
https://doi.org/10.3390/ijms19123708
Chicago/Turabian Style
Yamasaki, Koji, Shoichiro Mukai, Takahiro Nagai, Kozue Nakahara, Masato Fujii, Naoki Terada, Akinobu Ohno, Yuichiro Sato, Yoshinobu Toda, Hiroaki Kataoka,
and et al. 2018. "Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis" International Journal of Molecular Sciences 19, no. 12: 3708.
https://doi.org/10.3390/ijms19123708
APA Style
Yamasaki, K., Mukai, S., Nagai, T., Nakahara, K., Fujii, M., Terada, N., Ohno, A., Sato, Y., Toda, Y., Kataoka, H., & Kamoto, T.
(2018). Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. International Journal of Molecular Sciences, 19(12), 3708.
https://doi.org/10.3390/ijms19123708